Since 2016, CytoReason has been working toward a bold vision: transform medicine from trial and error to predictable practice.
For a decade, we've pioneered computational disease biology to turn the growing complexity of human molecular and clinical data into deeper disease biology understanding-helping scientists make better-informed decisions about the targets, assets, indications, combinations and patients that shape drug development.
Today, our technology informs high-priority R&D programs at leading pharmaceutical and biotechnology companies worldwide.
As biological data and computational capabilities advance faster than ever, our vision is becoming possible at unprecedented scale. And we're just getting started.
CytoReason brings together leaders across biology, medicine, data science, technology, and the pharmaceutical industry around one mission: advancing disease biology understanding to enable better R&D decisions.
Our Scientific & Clinical Advisory Board brings leading expertise across human biology, medicine, drug development, and computational science to help challenge and advance how we understand disease biology.
The latest from our science, technology, partnerships, people, and company.
Join scientists, engineers, data scientists, clinicians, and technology experts building new ways to understand human disease and help make drug development more predictable.
Biologists, clinicians, data scientists, engineers, mathematicians, and technologists work side by side at CytoReason to solve some of the most complex questions in human disease biology.
Our team includes many PhDs and experts with deep scientific and computational backgrounds-but no single discipline has all the answers. We bring these perspectives together to build technology that neither science nor data science could create alone.
CytoReason brings together people and partners across the world's leading life sciences ecosystems.